EvokAI Creative Labs (TSXV:OKAI) 3-Year EBITDA Growth Rate: 0.00% (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:OKAI EvokAI Creative Labs Inc TSXV:OKAI
15 GF Score
Price C$0.12
View Full Analysis

What is EvokAI Creative Labs 3-Year EBITDA Growth Rate?

EvokAI Creative Labs TSXV:OKAI 15 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2024. GuruFocus rates TSXV:OKAI with a GF Score™ of 15/100.

EvokAI Creative Labs's EBITDA per Share for the three months ended in Sep. 2024 was C$-0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

EvokAI Creative Labs  (TSXV:OKAI) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

EvokAI Creative Labs 3-Year EBITDA Growth Rate Related Terms

TSXV:OKAI vs VEEV, GEHC, DOCS: 3-Year EBITDA Growth Rate Comparison

For the Health Information Services subindustry, EvokAI Creative Labs's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EvokAI Creative Labs 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EvokAI Creative Labs's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where EvokAI Creative Labs's 3-Year EBITDA Growth Rate falls into.


TSXV:OKAI
15GF Score
EvokAI Creative Labs Inc TSXV:OKAI
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EvokAI Creative Labs 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 0.00% mean?
EvokAI Creative Labs (TSXV:OKAI) has a 3-Year EBITDA Growth Rate of 0.00% as of Sep. 2024. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for EvokAI Creative Labs and its competitors.
Is EvokAI Creative Labs' 3-Year EBITDA Growth Rate too high?
EvokAI Creative Labs' current 3-Year EBITDA Growth Rate is 0.00%. Overall, EvokAI Creative Labs has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does EvokAI Creative Labs' 3-Year EBITDA Growth Rate compare to VEEV and GEHC?
EvokAI Creative Labs' 3-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median 3-Year EBITDA Growth Rate is 10.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.20, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for EvokAI Creative Labs and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EvokAI Creative Labs's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EvokAI Creative Labs stock overvalued right now?
EvokAI Creative Labs (TSXV:OKAI) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. EvokAI Creative Labs' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For EvokAI Creative Labs (TSXV:OKAI), the current 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EvokAI Creative Labs Business Description

Address 609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.
15GF Score

Get the complete analysis for TSXV:OKAI

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.12
Price